Palisade Bio, Inc.
PALI
$1.87
-$0.05-2.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 193.37% | 4.95% | -26.22% | -6.79% | -16.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 195.12% | -18.68% | -32.49% | -37.11% | 15.47% |
| Operating Income | -195.12% | 18.68% | 32.49% | 37.11% | -15.47% |
| Income Before Tax | -166.12% | 17.75% | 31.76% | 36.77% | -12.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -166.12% | 17.75% | 31.76% | 36.77% | -12.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -166.12% | 17.75% | 31.76% | 36.77% | -12.55% |
| EBIT | -195.12% | 18.68% | 32.49% | 37.11% | -15.47% |
| EBITDA | -195.12% | 18.68% | 32.49% | 37.12% | -15.47% |
| EPS Basic | 97.20% | 83.49% | 82.53% | 89.87% | 67.82% |
| Normalized Basic EPS | 97.20% | 83.49% | 82.53% | 89.87% | 65.18% |
| EPS Diluted | 97.20% | 83.49% | 82.53% | 89.87% | 67.82% |
| Normalized Diluted EPS | 97.20% | 83.49% | 82.53% | 89.87% | 65.18% |
| Average Basic Shares Outstanding | 9,412.43% | 398.13% | 290.49% | 524.35% | 249.81% |
| Average Diluted Shares Outstanding | 9,412.43% | 398.13% | 290.49% | 524.35% | 249.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |